SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-135228
Filing Date
2022-05-02
Accepted
2022-05-02 06:17:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d232896ddefa14a.htm DEFA14A 11834
2 GRAPHIC g232896g22j90.jpg GRAPHIC 190182
3 GRAPHIC g232896g92l50.jpg GRAPHIC 68585
  Complete submission text file 0001193125-22-135228.txt   359037
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39614 | Film No.: 22879267
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences